Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Rocket Pharmaceuticals stock

Learn how to easily invest in Rocket Pharmaceuticals stock.

Rocket Pharmaceuticals Inc is a biotechnology business based in the US. Rocket Pharmaceuticals shares (RCKT) are listed on the NASDAQ and all prices are listed in US Dollars. Rocket Pharmaceuticals employs 151 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Rocket Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RCKT – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Rocket Pharmaceuticals stock price (NASDAQ: RCKT)

Use our graph to track the performance of RCKT stocks over time.

Rocket Pharmaceuticals shares at a glance

Information last updated 2022-10-04.
Latest market close$15.50
52-week range$7.57 - $36.87
50-day moving average $15.42
200-day moving average $15.37
Wall St. target price$54.80
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.69

Buy Rocket Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Rocket Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Rocket Pharmaceuticals price performance over time

Historical closes compared with the close of $15.5 from 2022-10-03

1 week (2022-09-27) 14.99%
1 month (2022-09-02) -0.26%
3 months (2022-07-01) 7.27%
6 months (2022-04-04) -6.85%
1 year (2021-10-04) -46.55%
2 years (2020-10-02) -33.49%
3 years (2019-10-04) 33.05%
5 years (2017-10-04) 659.80%

Rocket Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -24.59%
Return on equity TTM -43.72%
Profit margin 0%
Book value $5.89
Market capitalisation $1.1 billion

TTM: trailing 12 months

Rocket Pharmaceuticals share dividends

We're not expecting Rocket Pharmaceuticals to pay a dividend over the next 12 months.

Have Rocket Pharmaceuticals's shares ever split?

Rocket Pharmaceuticals's shares were split on a 1:4 basis on 4 January 2018. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Rocket Pharmaceuticals shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Rocket Pharmaceuticals shares which in turn could have impacted Rocket Pharmaceuticals's share price.

Rocket Pharmaceuticals share price volatility

Over the last 12 months, Rocket Pharmaceuticals's shares have ranged in value from as little as $7.565 up to $36.87. A popular way to gauge a stock's volatility is its "beta".

RCKT.US volatility(beta: 1.35)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Rocket Pharmaceuticals's is 1.346. This would suggest that Rocket Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Rocket Pharmaceuticals overview

Rocket Pharmaceuticals, Inc. , together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas (CIEMAT), Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; CIEMAT and UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey.

Frequently asked questions

What percentage of Rocket Pharmaceuticals is owned by insiders or institutions?
Currently 4.386% of Rocket Pharmaceuticals shares are held by insiders and 101.228% by institutions.
How many people work for Rocket Pharmaceuticals?
Latest data suggests 151 work at Rocket Pharmaceuticals.
When does the fiscal year end for Rocket Pharmaceuticals?
Rocket Pharmaceuticals's fiscal year ends in December.
Where is Rocket Pharmaceuticals based?
Rocket Pharmaceuticals's address is: 9 Cedarbrook Drive, Cranbury, NJ, United States, 08512
What is Rocket Pharmaceuticals's ISIN number?
Rocket Pharmaceuticals's international securities identification number is: US77313F1066
What is Rocket Pharmaceuticals's CUSIP number?
Rocket Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 45780V102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site